Mineral Trioxide Aggregate with or without Calcium Chloride in Pulpotomy.
The aim of this study was to evaluate the reaction of the pulp tissue against mineral trioxide aggregate (MTA) with or without 10% calcium chloride (CaCl(2)). Pulpotomies were performed in 4 canines and 8 premolars of two 8-month-old dogs. MTA with or without CaCl(2) was applied on the pulp tissue. The animals were killed after 90 days, and the specimens were processed for the microscopic analysis. Pulp tissue response was similar for MTA with and without CaCl(2). Pulp vitality was present in all specimens, along with pulp repair with formation of mineralized tissue bridging. The addition of CaCl(2) to MTA did not change its biologic properties in formation of mineralized barrier after pulpotomy.
Bortoluzzi
Eduardo Antunes
EA
Department of Endodontics, School of Dentistry, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil. edubortoluzzi@hotmail.com
Broon
Norberto Juárez
NJ
Bramante
Clovis Monteiro
CM
Consolaro
Alberto
A
Garcia
Roberto Brandão
RB
de Moraes
Ivaldo Gomes
IG
Bernadineli
Norberti
N
D017607:Aluminum Compounds / Q000627:therapeutic use*; D000818:Animals; D001641:Bicuspid / Q000187:drug effects; D002122:Calcium Chloride / Q000627:therapeutic use*; D017610:Calcium Compounds / Q000627:therapeutic use*; D003481:Cuspid / Q000187:drug effects; D003723:Dental Amalgam; D003782:Dental Pulp / Q000187:drug effects / Q000473:pathology; D003786:Dental Pulp Cavity / Q000187:drug effects / Q000473:pathology; D003793:Dental Restoration, Permanent; D003809:Dentin, Secondary / Q000187:drug effects / Q000473:pathology; D004285:Dogs; D004338:Drug Combinations; D008768:Methylmethacrylates / Q000627:therapeutic use; D009804:Odontoblasts / Q000187:drug effects / Q000473:pathology; D010087:Oxides / Q000627:therapeutic use*; D011672:Pulpotomy; D011897:Random Allocation; D012387:Root Canal Filling Materials / Q000627:therapeutic use*; D017640:Silicates / Q000627:therapeutic use*; D013997:Time Factors; D015035:Zinc Oxide-Eugenol Cement / Q000627:therapeutic use
D017607:Aluminum Compounds; D017610:Calcium Compounds; D004338:Drug Combinations; D008768:Methylmethacrylates; D010087:Oxides; D012387:Root Canal Filling Materials; D017640:Silicates; D015035:Zinc Oxide-Eugenol Cement; C086631:mineral trioxide aggregate; C031667:IRM cement; D003723:Dental Amalgam; D002122:Calcium Chloride